Skip to content

OS Therapies OSTX Other Income - Net

Other Income - Net at other companies

CTO
Citius Oncology, Inc.CTOR
$1.77M+4,003%

Segments

By segment

See full
Chief Operating Decision Maker-$228.89K-120%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's other income - net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's other income - net?
OS Therapies (OSTX) reported other income - net of -$228.89K in Q1 2026.
How has OS Therapies's other income - net changed year-over-year?
OS Therapies's other income - net decreased by 120.4% year-over-year, from $1.12M to -$228.89K.
What is the long-term trend for OS Therapies's other income - net?
Over 2 years (2023 to 2025), OS Therapies's other income - net has grown at a -88.2% compound annual growth rate (CAGR), from -$3.45M to -$48.14K.
What does other income - net mean?
The net result of all income and expenses that fall outside of the company's primary business operations. This provides a comprehensive view of the impact of financial activities, such as interest and currency effects, on the bottom line.